Who Controls Your Oil Price? 🛢️

No, not with new brick-and-mortar stores. With robotic kiosks from ART.

ART, aka Automated Retail Technologies, makes serving food 24/7 possible for brands like White Castle at .001% the cost of a new brick-and-mortar.

Their robotic kiosks dish out customers favorite dishes, like warm White Castle sliders, on demand in seconds.

That makes entering new markets a three-step process. Plug it in. Stock it. Turn it on. And it isn’t just White Castle benefitting.

Other big-name food brands like Nestlé and Macaroni Grille partnered too, and foodservice behemoths like Sysco and Aramark also use it. Even better, until April 25, you can earn guaranteed bonus stock as an early-stage ART investor and share in their growth.

Invest in ART Today

^{This is a paid advertisement for Automated Retail Technologies Regulation CF offering. Please read the offering circular at https://invest.automatedrt.com/}

The Strait of Hormuz is having a very bad weekend.

Iranian Revolutionary Guard gunboats opened fire on a tanker transiting the strait on Saturday. The British military confirmed it. The crew is reportedly safe. The vessel? Unnamed.

One-fifth of the world's oil flows through this stretch of water.

So yeah, markets should probably pay attention.

Here's the mess in order:

And then Trump complicated things further (as is tradition).

He initially seemed open to reopening the strait. Then walked it back. The U.S. blockade "will remain in full force," he said, until Iran agrees to a deal covering its nuclear programme.

So Iran is blocking ships from one end. The U.S. is blocking Iranian ports from the other. Both sides are using the strait as a chess piece.

The Pakistan-brokered ceasefire between Israel, the U.S. and Iran is technically still alive. But so is the standoff that could blow it up.

Iran's parliament security chief described the situation as returning to the "status quo". To be clear, means ships need Iranian permission and need to pay a toll. That's not open. That's a tollbooth with guns.

U.S. Central Command says it's already sent 21 ships back to Iran since the blockade began Monday.

The short version: Two nuclear-armed(ish) standoff participants are playing chicken with the global oil supply, and the exit ramp is a Pakistan-mediated peace deal that isn't signed yet.

1. Ride the Oil Spike
Iran just turned the world's busiest oil corridor into a checkpoint. Every headline out of the Strait sends crude jerking up or down. That volatility is tradeable.

📌 Action: Buy into oil ETFs like $USO ( ▼ 7.79% ) or $BNO ( ▼ 7.36% ) on de-escalation dips. Sell into the fear spikes when tensions flare again.

2. Stack Defence
The U.S. has deployed warships, initiated a naval blockade and is deep in a three-way standoff. Defence budgets don't shrink during moments like this.

📌 Action: Add exposure to $LMT ( ▼ 2.52% ) (Lockheed Martin) or $RTX ( ▲ 0.29% ) (Raytheon). Both directly tied to U.S. military escalation cycles.

3. Bet on the Detour
If the Strait stays blocked, global shipping reroutes the long way around Africa. That's more miles, more fuel, more demand for alternative energy infrastructure.

📌 Action: Look at LNG shipping plays like $FLNG ( ▼ 1.0% ) or broader energy infrastructure via $MLPX ( ▼ 0.77% ) as supply chains scramble to adapt.

For years, investors ignored nuclear.

Now energy demand is rising, supply is tight, and governments are backing buildouts.

Yet parts of the sector still trade as if nothing changed.

The 7 Top Nuclear Stocks to Buy Now report highlights companies leading this rally and positioned to benefit as momentum builds.

Send My Free Report

The Feds think your $9 eggs weren’t an accident.

The Department of Justice is reportedly gearing up to sue some of America's biggest egg producers. And the allegation is exactly what it sounds like.

Price fixing.

According to the Wall Street Journal, rival egg producers coordinated by sharing pricing data through Expana, a third-party service that sets industry benchmark prices using sales data.

Think of Expana as the group chat where competitors "just happened" to share what they were charging.

The companies in the crosshairs? Cal-Maine Foods $CALM ( ▲ 0.38% ) and Versova are among those implicated. Both significantly hiked prices in 2024 and 2025, blaming a bird flu-driven supply crunch.

Markets didn't love the news. CALM $CALM ( ▲ 0.38% ) and Vital Farms $VITL ( ▼ 1.44% ) both dropped in post-market trading after the WSJ story dropped Friday.

To be fair, the DOJ hasn't pulled the trigger yet. A settlement is still on the table, which would let producers dodge the lawsuit entirely.

The American Egg Board — yes, that's a real lobbying group — fired back with this gem: "Egg farmers are price takers. They don't set prices; the market does."

Sure. The market. Not the shared pricing spreadsheet.

The White House went full tie-dye on Saturday.

Trump signed an executive order to fast-track research and patient access to psychedelic treatments, including psilocybin, ibogaine, LSD, and MDMA.

His words, not ours: "Life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans."

RFK Jr. was in the room. Of course he was.

HHS is now tasked with accelerating research, approval, and access to psychedelic therapies. FDA Commissioner Marty Makary went further, announcing three national priority vouchers for psychedelics. It’s a programme designed to turbocharge the review process for drugs aligned with national priorities.

And he didn't bury the lede:

"Drugs can get approved in weeks — not a year or a year plus, but in weeks."

Weeks. For drug approvals. That's not a typo.

Markets didn't wait for the ink to dry. Psychedelic stocks were already ripping on Thursday after CBS News leaked the plan. By the time the pen hit paper, the sector had a head start.

Stocks to watch:

This is still early-stage, high-risk territory. But when the White House puts rocket fuel under an approval process, the market listens.

1. Ride the Psychedelic Sector Surge
Trump's EO just put rocket fuel under an entire niche sector. FDA approvals in weeks means the runway for these stocks just got a lot shorter.

📌 Action: Buy into diversified psychedelic exposure via $ATAI ( ▼ 1.47% ) or $CMPS ( 0.0% ). Watch for approval news as the next catalyst.

2. Target the FDA Fast-Track Winners
Three national priority vouchers are being handed out. Whoever gets them sees their approval timeline collapse. That's a stock-moving event.

📌 Action: Watch $GHRS ( ▲ 3.38% ) and $HELP ( 0.0% ) closely. Either could be a voucher recipient. A small speculative position now could pay off on the announcement.

3. Play the Veteran Mental Health Tailwind
Trump specifically name-dropped veterans. That's a political signal that federal funding and support for psychedelic therapy is coming.

📌 Action: $DFTX ( ▲ 0.98% ) is early stage but aligned with this narrative. Small position, high risk, high upside if federal contracts follow the rhetoric.